SHERMAN STEVEN 4/A
4/A · EKSO BIONICS HOLDINGS, INC. · Filed May 17, 2023
Insider Transaction Report
Form 4/AAmended
SHERMAN STEVEN
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-08+15,599→ 55,564 total - Exercise/Conversion
Restricted Stock Units
2022-03-08−15,599→ 171,591 total→ Common Stock (15,599 underlying)
Footnotes (3)
- [F1]On March 10, 2022, the Reporting Person filed a Form 4 that did not reflect the decrease in the Reporting Person's holdings caused by the Issuer's 1-for-15 reverse stock split effected on March 24, 2020. This Amendment corrects such inaccuracies.
- [F2]Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022.
- [F3]The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement.